ORIGINAL RESEARCH
Published on 11 Dec 2024
TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC
doi 10.3389/fimmu.2024.1499731
- 1,406 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Response/Resistance to PD-1 Axis Inhibitors: Focus on the Tumor Microenvironment
Response/Resistance to PD-1 Axis Inhibitors: Focus on the Tumor Microenvironment
12k
Total downloads
33k
Total views and downloads
Articles
REVIEW
Published on 03 Dec 2024
Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers
doi 10.3389/fimmu.2024.1487610
- 691 views
ORIGINAL RESEARCH
Published on 02 Dec 2024
PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1
doi 10.3389/fimmu.2024.1486888
- 850 views
ORIGINAL RESEARCH
Published on 15 Oct 2024
PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop
doi 10.3389/fimmu.2024.1452212
- 1,379 views
CLINICAL TRIAL
Published on 23 Sep 2024
Opioid−free anesthesia attenuates perioperative immunosuppression by regulating macrophages polarization in gastric cancer patients treated with neoadjuvant PD-1 inhibitor
doi 10.3389/fimmu.2024.1438859
- 1,234 views
- 1 citation
ORIGINAL RESEARCH
Published on 28 Jun 2024
Training immunophenotyping deep learning models with the same-section ground truth cell label derivation method improves virtual staining accuracy
doi 10.3389/fimmu.2024.1404640
- 1,837 views
- 1 citation
CASE REPORT
Published on 31 May 2024
Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report
doi 10.3389/fimmu.2024.1371379
- 953 views
- 1 citation
ORIGINAL RESEARCH
Published on 11 Apr 2024
The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy
doi 10.3389/fimmu.2024.1358306
- 1,359 views
- 1 citation
REVIEW
Published on 10 Apr 2024
Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis
doi 10.3389/fimmu.2024.1366489
- 1,709 views
BRIEF RESEARCH REPORT
Published on 12 Mar 2024
Role of CD38 in anti-tumor immunity of small cell lung cancer
doi 10.3389/fimmu.2024.1348982
- 2,416 views
- 3 citations
REVIEW
Published on 07 Feb 2024
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
doi 10.3389/fimmu.2024.1342086
- 5,003 views
- 7 citations
STUDY PROTOCOL
Published on 15 Jan 2024
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)
doi 10.3389/fimmu.2023.1341584
- 2,778 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore